After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Merck Makes Another Big R&D Investment with $3.5B Orna Deal
Roche’s Polivy continues its regulatory dance, will head to FDA for a form of blood cancer
‘Treg’ cell therapy: bringing CAR-T to autoimmune disease
*please scroll down for all the latest news*
